Why the study?
Does balloon pulmonary angioplasty improve hemodynamics and symptoms in a patient with CTEPH and a single lung?
Does balloon pulmonary angioplasty improve hemodynamics and symptoms in a patient with CTEPH and a single lung?
Balloon pulmonary angioplasty combined with sildenafil can be safely and effectively performed in a high-risk CTEPH patient with a single lung.
Supports BPA feasibility in CTEPH with single lung; leaves open need for prospective validation.
A 46-year-old man 1 year after left-sided pneumonectomy for squamous cell lung cancer presented with severely limited exercise tolerance and dyspnea corresponding to World Health Organization functional class IV (WHO Class IV). After right heart catheterization (RHC), mean pulmonary artery pressure (mPAP) was 43 mmHg and pulmonary vascular resistance (PVR) was 10.2 Wood units (WU). Arteriography revealed organized clots located at the proximal level of the right pulmonary artery, leading to a diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH). The CTEPH team disqualified the patient from surgical treatment due to high perioperative risk and referred him for balloon pulmonary angioplasty (BPA) together with pulmonary hypertension-specific pharmacotherapy (sildenafil). The patient underwent a cycle of nine BPA sessions and completed treatment without complications. Follow-up showed sustained hemodynamic improvement in RHC (mPAP 23 mmHg, PVR 2.6 WU), improved physical capacity (WHO Class II), and relief of dyspnea symptoms.
No takes yet. Share an insight, caveat, or question.
Darocha et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: